Possible IND filing for Gralyse program, European partnership. Most likely both happen in 2nd half of 2012, but the time to buy is now before news hits. With close to $3/share in cash and first Phase III already complete, the stock is substantially de-risked from a neg event happening.
Ive slowly been adding to my position over the past 3-4 months, is my 3rd biggest biotech holding.
If u are looking for a stock with a big catalyst in the next 3-6 months, check out EXAS, their phase 3 trial should complete June-July and expect great results from the Deep-C trial. Management is top notch, Kevin Conroy one of the best CEO's out there in biotech.
I like the prospectus of TSRX, but I'm not sure that leaving a lot of cash here will do much for me right now. For example, I could exit my position here for a month or two and come back at the same PPS. I'm long only 2k shares right now. I think we'll see 10+ later this year though.